cathepsin
group
proteolyt
enzym
classic
lysosom
origin
vari
class
ph
optimum
target
specif
inhibit
function
nearli
univers
express
eukaryot
organ
regul
rang
physiolog
process
befit
vari
attribut
target
prefer
subset
cysteinyl
character
origin
lysosom
locat
function
later
work
uncov
addit
role
intracellular
extracellular
locat
enzym
cleav
specif
substrat
involv
antigen
present
collagen
turnov
bone
cartilag
process
endogen
bioactiv
peptid
leukocyt
penetr
cellular
monolay
matrix
wide
express
cystein
proteas
cathepsin
l
ctsl
implic
sever
type
patholog
potenti
pharmaceut
target
inhibit
control
inflamm
counterproduct
immun
respons
exampl
cleav
viral
protein
ctsl
help
ebola
hendra
sever
acut
respiratori
syndrom
sar
virus
infect
host
cell
therebi
advanc
infect
hand
epitheli
cell
thymic
cortex
ctsl
play
key
role
remov
placehold
class
iiassoci
invari
chain
peptid
import
posit
select
cell
bind
mhc
protein
cell
role
cell
matur
influenc
mhcrestrict
present
respons
extracellular
antigen
bacteria
previou
studi
laboratori
reveal
ctsl
critic
defens
lung
infect
mycoplasma
pulmoni
extracellular
pathogen
mani
respiratori
pathogen
includ
orthomyxoviru
influenza
publish
data
indic
whether
ctsl
promot
infect
suggest
viral
pathogen
mitig
mycoplasma
infect
influenza
virus
among
common
patholog
signific
caus
human
respiratori
infect
influenza
epidem
associ
major
spike
mortal
everi
year
worldwid
fortun
rare
sever
pandem
caus
new
form
viru
catastroph
influenza
prevent
vaccin
howev
may
partial
complet
ineffect
lack
major
epitop
strain
preval
given
year
antivir
treatment
avail
activ
infect
caus
strain
influenza
reduc
influenza
sever
durat
often
limit
efficaci
among
potenti
altern
approach
proteas
inhibit
potenti
strategi
cleavag
influenza
viru
surfac
hemagglutinin
host
cell
proteas
prerequisit
infect
pathogen
sever
candid
influenza
aactiv
proteas
identifi
includ
host
epitheli
proteas
influenza
strainselect
identifi
influenza
virusactiv
proteas
extracellular
serin
proteas
tryptic
specif
howev
recent
evid
suggest
calpain
noncathepsin
neutral
cytosol
cysteinyl
proteinas
promot
influenza
mice
calpain
inhibitor
reduc
influenzaassoci
mortal
extent
calpain
effect
mediat
cleavageactiv
viru
yet
clear
like
calpain
ctsl
cysteinyl
proteinas
differ
acid
ph
optimum
optim
activ
lysosom
ctsl
cleav
target
tryptic
site
also
nontrypt
site
particularli
protein
coloc
lysosom
outsid
cell
ctsl
activ
limit
neutral
alkalin
ph
typic
extracellular
environ
oppos
extracellular
inhibitor
cystatin
ground
hypothes
ctsl
less
like
major
vivo
activ
influenza
support
host
defens
infect
hypothesi
predict
influenza
sever
mice
lack
ctsl
present
work
test
predict
compar
immun
histopatholog
respons
wildtyp
ctsldefici
mice
studi
use
male
femal
ctsl
mice
describ
origin
nakagawa
colleagu
receiv
univers
california
san
francisco
background
shi
colleagu
backcross
gener
background
male
femal
ctsl
mice
serv
wildtyp
control
studi
conduct
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
protocol
number
approv
univers
california
san
francisco
institut
anim
care
use
committe
mice
week
age
begin
studi
anesthet
inocul
intranas
pb
contain
focusform
unit
ffu
influenza
steril
pb
alon
sham
infect
mice
weigh
everi
two
day
anim
determin
lost
bodi
weight
moribund
indic
increas
respiratori
rate
inabl
ambul
euthan
infect
mice
sacrif
interv
day
pneumonia
sever
grade
histopatholog
describ
beck
colleagu
mice
infect
influenza
briefli
score
assign
accord
degre
tissu
infiltr
inflammatori
cell
inflamm
mild
influx
inflammatori
cell
cuf
around
vessel
increas
inflamm
involv
lung
sever
inflamm
involv
lung
lung
infiltr
inflammatori
cell
detect
lung
airway
fibrosi
addit
tissu
section
stain
masson
trichrom
american
mastertech
lodi
ca
usa
day
infect
lung
ffu
measur
day
viral
inocul
activat
viru
assay
applic
stock
viru
extract
whole
lung
homogen
ml
pb
apic
surfac
madindarbi
canin
kidney
mdck
cell
american
type
cultur
collect
manassu
va
usa
grown
confluenc
individu
well
plate
h
sampl
decant
replac
serumfre
medium
contain
l
ethyl
chloromethyl
ketonetr
bovin
trypsin
activ
uncleav
viru
sixteen
hour
later
cell
fix
cold
methanol
foci
infect
detect
immunocytochem
incub
polyclon
goat
antiinfluenza
igg
emd
millipor
billerica
usa
follow
amplif
detect
use
biotinyl
rabbit
antigoat
igg
santa
cruz
biotechnolog
dalla
tx
usa
histostainsp
streptavidinperoxidas
diaminobenzidin
chromogen
invitrogen
camarillo
ca
usa
serial
dilut
sampl
process
triplic
lung
ffu
estim
count
well
dilut
yield
discret
foci
obtain
bal
fluid
analysi
steril
cathet
insert
expos
tracheal
lumen
anesthet
mice
bal
fluid
collect
one
aliquot
pb
per
mous
place
ice
centrifug
supernat
store
cell
pellet
resuspend
pb
live
cell
count
stain
trypan
blue
differenti
cell
count
obtain
cytospun
cell
stain
diffquik
american
scientif
product
mcgaw
park
il
usa
type
analysi
surfac
protein
express
bal
cell
transfer
fac
buffer
pb
albumin
sodium
azid
cell
divid
stain
either
fitc
ucsf
antibodi
core
facil
san
francisco
ca
usa
pe
bd
pharmingen
san
diego
ca
usa
ebiosci
san
diego
ca
usa
apc
ebiosci
fitc
southern
biotech
birmingham
al
usa
pe
bd
pharmingen
bd
pharmingen
apc
anti
miltenyi
biotec
san
diego
ca
usa
bd
pharmingen
cell
stain
min
ice
wash
fix
paraformaldehyd
sigmaaldrich
st
loui
mo
usa
analyz
use
navio
flow
cytomet
beckman
coulter
brea
ca
usa
spleen
excis
euthan
mice
place
pb
splenocyt
extract
pass
spleen
though
wire
mesh
wash
media
contain
rpmi
fetal
calf
serum
penicillin
streptomycin
cell
filter
nylon
mesh
elko
miami
garden
fl
usa
transfer
fac
buffer
label
fluoresc
probe
subject
flow
cytometri
describ
cell
obtain
bal
fluid
lung
fix
neutral
formaldehyd
dehydr
seri
grade
ethanol
solut
embed
paraffin
immunohistochem
detect
virusinfect
cell
tissu
section
incub
overnight
polyclon
goat
antiinfluenza
emd
millipor
h
rabbit
antigoat
biotin
santa
cruz
biotechnolog
follow
amplif
visual
histostainsp
diaminobenzidinebas
invitrogen
counterstain
hematoxylin
immunoreact
quantit
compar
infect
ctsl
ctsl
lung
section
use
ihc
toolbox
plugin
imagej
softwar
nation
institut
health
support
autom
select
statist
detect
brown
color
gener
diaminobenzidin
stain
random
microscop
field
tissu
section
individu
well
immunoassay
plate
coat
influenza
antigen
x
ffuwel
carbon
buffer
ph
incub
overnight
well
incub
h
bsapb
block
nonspecif
bind
serum
experiment
anim
dilut
detect
detect
iga
ige
igm
dilut
serial
fashion
bsa
dilut
serum
well
mix
biotinyl
antimous
iga
ige
igm
solut
bd
pharmingen
incub
overnight
follow
addit
alkalin
phosphataseconjug
streptavidin
jackson
immunoresearch
west
grove
pa
usa
alkalin
phosphatas
activ
remain
bound
wash
detect
use
phosphatas
substrat
phosphat
sigmaaldrich
spectrophotometr
monitor
cleav
substrat
nm
level
bal
fluid
lung
extract
assay
elisa
kit
pbl
assay
scienc
piscataway
nj
usa
monocyt
chemoattract
protein
ebiosci
macrophag
inflammatori
protein
r
system
minneapoli
mn
usa
bd
pharmingen
data
compar
ttest
logrank
test
surviv
data
oneway
anova
bonferroni
test
pair
group
p
consid
signific
investig
overal
sever
influenza
bodi
weight
mortal
compar
agematch
ctsl
ctsl
mice
type
mice
lost
weight
infect
fig
survivor
among
infect
mice
group
began
regain
weight
approxim
day
signific
differ
weight
chang
found
two
type
infect
mice
howev
mortal
fig
much
higher
infect
ctsl
mice
versu
ctsl
mice
receiv
ident
inocula
p
evalu
sever
airway
lung
inflamm
infect
lung
histopatholog
pneumonia
score
compar
ctsl
ctsl
mice
infect
mice
develop
lung
infiltr
inflammatori
cell
persist
least
day
fig
type
mice
develop
predominantli
mononuclear
pneumonia
associ
airway
exud
within
day
infect
day
infect
type
surviv
mice
manifest
sever
inflamm
day
pneumonia
mononuclear
cell
infiltr
remain
sever
decreas
histopatholog
score
quantifi
fig
reveal
pneumonia
sever
peak
day
surviv
mice
decreas
without
signific
differ
infect
ctsl
ctsl
mice
analysi
tissu
harvest
day
infect
reveal
addit
lumin
peribronchi
mononuclear
cell
infiltr
alreadi
describ
bronchial
alveolar
epitheli
necrosi
loss
line
cell
fig
patchi
contrast
strikingli
specimen
shaminfect
mice
day
initi
infect
tissu
manifest
focal
epitheli
metaplasia
airway
well
alveolar
bronchiol
lung
section
deriv
genotyp
surviv
mice
persist
patch
larg
mononuclear
inflamm
fig
fig
area
bronchiol
appear
repres
coverag
monolay
noncili
cuboid
claralik
cell
tend
produc
tumorlik
bloom
sharpli
demarc
adjac
normal
lung
fig
appear
correspond
keratin
pod
observ
vaughan
kumar
colleagu
mice
day
process
appear
evolv
desquam
regener
epithelium
leav
cystic
space
like
incap
ga
transfer
fig
fig
howev
region
lung
parenchyma
larg
intact
unaffect
mice
surviv
infect
masson
trichrom
stain
reveal
fibrosi
affect
region
day
howev
differ
collagen
deposit
airway
wall
alveolar
interstitium
observ
infect
ctsl
ctsl
mice
shown
fig
result
reveal
influenza
lead
lung
remodel
present
immunohistochem
evid
activ
infect
disappear
local
lung
tissu
site
influenza
infect
compar
persist
pathogen
ctsl
ctsl
mice
viru
detect
immunohistochem
lung
tissu
section
incub
antiinfluenza
antibodi
analysi
section
obtain
lung
harvest
interv
infect
reveal
viral
antigen
persist
lung
airway
epithelium
day
ctsl
mice
fig
howev
greater
viral
burden
detect
ctsl
lung
ctsl
lung
day
quantifi
analysi
pixel
color
correspond
viral
protein
immunoreact
microscop
field
fig
immunoreact
detect
either
group
mice
day
infect
data
suggest
infect
last
longer
ctsl
mice
explor
viral
expans
infect
lung
test
whether
ctsl
defici
impair
antivir
defens
influenza
ffu
assess
lung
extract
influenza
ffu
increas
ctsl
mice
rel
ffu
infect
inoculum
compar
increas
ctsl
lung
thu
shown
fig
ctsl
lung
extract
activat
influenza
viru
ctsl
lung
extract
day
infect
data
suggest
ctsl
mice
less
effect
ctsl
mice
limit
viral
replic
earli
cours
infect
assess
lumenspecif
lung
inflamm
inflammatori
cell
infiltr
evid
histolog
examin
lung
bal
fluid
cell
assess
ctsl
ctsl
mice
day
infect
shaminfect
mice
shaminfect
anim
total
cell
bal
fluid
cytolog
differenti
profil
similar
ctsl
ctsl
mice
neutrophil
uncommon
shown
fig
inflammatori
cell
bal
fluid
increas
infect
type
mice
dramat
time
point
bal
retriev
macrophag
lymphocytesmonocyt
neutrophil
fewer
cell
infect
ctsl
ctsl
mice
day
signific
differ
cell
infect
ctsl
ctsl
mice
studi
focus
time
point
death
start
occur
genotyp
infect
mice
character
quantit
subset
inflammatori
cell
bal
fluid
flow
cytometri
fig
splenocyt
prepar
fig
reveal
modestli
higher
percentag
splenic
neutrophil
infect
ctsl
mice
comparison
infect
ctsl
mice
conspicu
differ
cell
profoundli
defici
ctsl
mice
baselin
day
infect
signific
differ
cell
antiinfluenza
igm
titer
lower
infect
ctsl
mice
infect
ctsl
mice
time
point
fig
differ
signific
p
day
respect
titer
detect
influenza
anaiv
mice
support
specif
antibodi
influenza
antiinfluenza
first
detect
day
infect
significantli
lower
ctsl
mice
ctsl
mice
antiinfluenza
detect
later
infect
ctsl
mice
ctsl
mice
titer
undetect
day
significantli
lower
ctsl
mice
ctsl
mice
day
antiinfluenza
iga
ige
detect
time
point
find
suggest
humor
respons
influenza
ctsl
mice
impair
assess
whether
pulmonari
respons
influenza
ctsl
mice
differ
ctsl
mice
compar
bal
fluid
andor
lung
level
select
protein
bal
fluid
level
increas
follow
infect
level
significantli
higher
ctsl
mice
ctsl
mice
day
respect
fig
lung
tissu
level
cytokin
chemokin
increas
slightli
infect
signific
differ
found
ctsl
ctsl
mice
data
shown
thu
data
suggest
defici
product
measur
cytokin
chemokin
basi
observ
differ
respons
influenza
ctsl
versu
ctsl
mice
previou
report
suggest
ctsl
cleav
pathogenassoci
protein
help
ebola
hendra
sar
virus
enter
cell
therebi
advanc
infect
ctsl
also
allow
nonenvelop
reoviru
enter
cell
digest
outer
capsid
protein
form
infecti
subvirion
exampl
ebola
viru
although
certain
cathepsin
activ
form
viru
cell
cultur
mice
genet
defici
cathepsin
protect
infect
vivo
reveal
viral
activ
data
gener
cell
cultur
necessarili
predict
vivo
consequ
regard
present
studi
rule
possibl
ctsl
activ
influenza
orthomyxovirus
requir
process
host
proteas
becom
infecti
howev
find
suggest
ctsl
domin
contribut
defens
infect
presenc
mice
limit
respiratori
viral
burden
improv
likelihood
surviv
infect
higher
mortal
infect
ctsl
mice
like
relat
observ
higher
viru
burden
earli
infect
well
persist
viru
later
stage
infect
consequ
sever
sustain
damag
lung
airway
although
histopatholog
respons
infect
similar
ctsl
ctsl
mice
interv
infect
reflect
inflamm
score
shown
fig
dropout
mice
die
infect
via
survivor
effect
may
caus
underestim
sever
inflamm
ctsl
cohort
experienc
greater
mortal
ultim
poorer
outcom
ctsl
mice
attribut
rel
defect
innat
immun
pathogenspecif
adapt
respons
suggest
lower
titer
igg
infect
ctsl
mice
rel
infect
ctsl
mice
given
cite
prior
work
suggest
ctsl
enhanc
noninfluenza
viral
infect
larg
base
observ
cultur
cell
possibl
vivo
infect
relat
virus
ctsl
mice
would
poorli
toler
due
immun
deficit
notwithstand
reduct
direct
viral
activ
attribut
ctsl
absenc
ctsl
requir
degrad
invari
chain
cortic
thymic
epitheli
cell
ctsl
mice
decreas
posit
select
develop
cell
ctsl
defici
also
alter
pool
peptid
gener
mhc
class
ii
present
thu
quantit
qualit
defect
cell
repertoir
reflect
profoundli
depress
proport
splenocyt
ctsl
mice
baselin
infect
may
result
impair
earli
host
defens
although
detect
differ
earli
type
interferon
respons
type
impair
may
present
exampl
differ
nucleic
acidsens
surfac
protein
like
tolllik
receptor
contribut
innat
recognit
influenza
viru
rna
cytokin
product
infect
macrophag
activ
part
ctsl
also
may
contribut
observ
earli
deficit
control
influenza
ctsl
mice
cell
ctsl
contribut
antigen
process
prior
present
mhc
ii
could
lead
defect
cellular
well
primari
humor
respons
addit
establish
influenc
virusspecif
cell
respons
memori
respons
longterm
protect
immun
profoundli
depress
proport
splenocyt
ctsl
mice
baselin
infect
may
reflect
gener
defici
develop
lymphocyt
consequ
impair
earli
host
defens
defect
could
includ
earli
respons
involv
innat
heterotyp
preexist
virusspecif
cell
appear
protect
human
sever
influenza
absenc
detect
pathogenspecif
antibodi
possibl
activ
recent
recogn
cytotox
potenti
cell
act
mhc
iiexpress
epitheli
cell
deficit
cell
would
also
tend
limit
abil
augment
kill
efficaci
macrophag
ctsl
mice
fewer
cell
defect
pathogenspecif
lymphocyt
respons
antigen
shown
exampl
studi
mycoplasma
pulmoni
infect
ctsl
mice
howev
mycoplasma
studi
major
differ
ctsl
ctsl
mice
humor
respons
mycoplasma
antigen
observ
manifest
titer
antibodi
serum
thu
mycoplasma
influenza
pathogen
may
differ
manner
provok
humor
respons
may
relat
pulmoni
extracellular
pathogen
wherea
influenza
infect
kill
lyse
target
cell
anoth
overt
differ
two
pathogen
mice
primari
natur
evok
inflamm
larg
neutrophil
mycoplasma
larg
monocyticlymphocyt
influenza
studi
differ
inflammatori
respons
could
associ
differ
mode
antigen
process
present
turn
yield
differ
cellular
humor
adapt
respons
promin
bloom
bronchiol
observ
adjac
normal
lung
type
mice
two
week
infect
similar
histolog
chang
report
lung
autopsi
human
victim
pandem
influenza
howev
mani
fatal
case
influenza
associ
secondari
bacteri
pneumonia
associ
dens
infiltr
lung
parenchyma
neutrophil
seen
influenzainfect
mice
although
number
neutrophil
retriev
bal
increas
infect
mice
higher
time
point
ctsl
mice
ctsl
mice
neutrophil
remain
small
fraction
total
leukocyt
examin
interv
infect
whether
repres
fundament
differ
human
mice
respons
influenza
infect
differ
viral
strain
survivor
effect
human
sampl
exclus
obtain
individu
die
infect
rel
protect
bacteri
infect
mice
hous
barrier
facil
combin
factor
remain
determin
case
histopatholog
lung
parenchyma
week
infect
suggest
bronchiol
area
natur
evolv
process
epitheli
replac
repair
cystic
air
space
sometim
surround
fibrosi
area
repres
return
normal
alveoli
like
nonfunct
may
repres
perman
damag
gasexchang
surfac
lung
may
also
occur
human
sever
influenza
pneumonia
respiratori
distress
overal
result
suggest
critic
role
ctsl
contain
airway
influenza
infect
mice
influenza
caus
endur
structur
chang
alveoli
small
airway
unlik
effect
virus
ctsl
seem
augment
influenza
viru
infect
reflect
compar
viral
titer
tissu
viral
immunoreact
ctsl
ctsl
mice
howev
ctsl
mice
defect
immun
respons
may
contribut
higher
mortal
influenza
compar
mortal
ctsl
mice
find
also
suggest
target
ctsl
pharmacolog
inhibit
part
antiinflammatori
immunosuppress
antivir
strategi
suggest
sar
coronaviru
carri
potenti
risk
impair
host
defens
orthomyxovirus
like
influenza
